Newsbenzinga
AbbVie's RINVOQ Wins European Commission Approval For Non-Segmental Vitiligo, First Systemic Medication Approved In EU For This Condition
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…